130
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Managing SARS-CoV2 Infections Through Resolution of Inflammation by Eicosanoids: A Review

ORCID Icon, & ORCID Icon
Pages 4349-4358 | Published online: 29 Jul 2022

Figures & data

Figure 1 Overview of cyclooxygenase (COX) and lipoxygenase (LOX) pathways, generating prostanoids and leukotrienes, respectively, in response to inflammatory stimuli.

Figure 1 Overview of cyclooxygenase (COX) and lipoxygenase (LOX) pathways, generating prostanoids and leukotrienes, respectively, in response to inflammatory stimuli.

Figure 2 The role of eicosanoids in the mediation of inflammation and resolution through class-switching and thus in the maintenance of homeostasis.

Figure 2 The role of eicosanoids in the mediation of inflammation and resolution through class-switching and thus in the maintenance of homeostasis.

Figure 3 An interplay of pro-and anti-lipid mediators in mediating the cytokine storm and the potential therapeutic role of specialized pro-resolving mediators (SPMs) in the resolution of inflammation during SARS CoV-2 infection.

Figure 3 An interplay of pro-and anti-lipid mediators in mediating the cytokine storm and the potential therapeutic role of specialized pro-resolving mediators (SPMs) in the resolution of inflammation during SARS CoV-2 infection.